pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,993 catalysts · 18,987 approval · 5,811 phase readout · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 0 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 14 catalysts2026-08-11: 11 catalysts2026-08-12: 15 catalysts2026-08-13: 14 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 1 catalyst2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 10 catalysts2026-10-29: 19 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: filing×type: approval×clear all
type
  • approval18,987
  • phase readout5,811
  • device 510k5,000
  • grant4,728
  • 8k filing2,984
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings532
  • therapy area
    • Ophthalmology5

    Week of Dec 8, 2014

    3
    ›Dec 13, 2014approval4256d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

    Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 13, 2014approval4256d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 13, 2014approval4256d agoMYORISAN (ISOTRETINOIN) — FDA approvalSun Pharmaceutical Industries Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗

    Week of Dec 15, 2014

    47
    ›Dec 15, 2014approval4254d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 15, 2014approval
    ← prev
    page 148 of 380
    next →
    4254d ago
    VALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2014approval4254d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 15, 2014approval4254d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 16, 2014approval4253d agoWELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Dec 16, 2014approval4253d agoWELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Dec 17, 2014approval4252d agoXTORO (FINAFLOXACIN) — FDA approval

    Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Dec 18, 2014approval4251d agoTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 18, 2014approval4251d agoTOPAMAX (TOPIRAMATE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 18, 2014approval4251d agoOXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PH HEALTH. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoTRULICITY (DULAGLUTIDE) — FDA approvaldulaglutide

    Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION

    full page →dulaglutide →fda approvals ↗
    ›Dec 19, 2014approval4250d agoZYPREXA ZYDIS (OLANZAPINE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

    Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoZYPREXA (OLANZAPINE) — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHEPLAPHARM. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

    Sponsor: TEVA PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: TABLET. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Dec 19, 2014approval4250d agoTIVICAY (DOLUTEGRAVIR SODIUM) — FDA approvalViiV Healthcare Company

    Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 19, 2014approval4250d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Dec 20, 2014approval4249d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Dec 20, 2014approval4249d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Dec 20, 2014approval4249d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Dec 20, 2014approval4249d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

    Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

    full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Dec 20, 2014approval4249d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

    Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

    full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Dec 20, 2014approval4249d agoEPIRUBICIN HYDROCHLORIDE — FDA approvalEPIRUBICIN HYDROCHLORIDE

    Sponsor: CIPLA LTD. Form: INJECTABLE. Route: INJECTION

    full page →EPIRUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Dec 21, 2014approval4248d agoONDANSETRON — FDA approvalondansetron ODT

    Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →ondansetron ODT →fda approvals ↗
    ›Dec 21, 2014approval4248d agoONDANSETRON — FDA approvalondansetron ODT

    Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →ondansetron ODT →fda approvals ↗
    $ABBV246.04+0.89%
    $LLY1185.71-0.52%
    $RDY12.22+0.91%
    $TEVA35.36+1.58%
    $TEVA35.36+1.58%
    $RDY12.22+0.91%
    $AMRX18.14+0.39%
    $RDHL0.7390+6.64%
    $RDHL0.7390+6.64%
    $RDY12.22+0.91%
    $RDY12.22+0.91%
    $RDY12.22+0.91%
    $RDY12.22+0.91%
    $RDY12.22+0.91%